By Tony Fong

NEW YORK (GenomeWeb News) – For most of 2010, the IPO market froze out the life science tools and 'omics market, but by the end of the summer, there were signs that the public markets may be slowly welcoming firms operating in the space, as a handful of public offerings ended a cold snap.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.